Bharat Biotech’s ‘COVAXIN’ gets approval for phase 3 trials in India
Team Udayavani, Oct 23, 2020, 9:26 AM IST
Covaxin, the coronavirus vaccine being developed by Bharat Biotech and ICMR, has received the approval by the Drugs Controller General of India (DCGI) to conduct the third phase of clinical trials.
The expert panel’s approval came after assessing data from Phases 1 and 2 along with animal trials. However, the committee suggested “minor amendments” in the protocol.
The study would cover 28,500 participants aged 18 years and above across 10 states. The Serum Institute of India began phase 3 clinical trial of Oxford vaccine last month.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Mumbai terror accused Rana approaches US Supreme Court to challenge extradition to India
Who will be next Maharashtra CM? Mahayuti, MVA constituents drop different names
PM Modi leaves for home after concluding three-nation visit
Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’
Kerala HC quashes FIR against Goa Guv over remarks on Sabarimala women entry
MUST WATCH
Latest Additions
Only ineligible BPL cards cancelled: Dinesh Gundu Rao
Fraudsters create fake FB profile misusing Udupi DC’s identity, case filed
Investigation begins into Naxal Encounter; Where did the others escape?
Mumbai terror accused Rana approaches US Supreme Court to challenge extradition to India
Who will be next Maharashtra CM? Mahayuti, MVA constituents drop different names
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.